Author

José M. Villalba

University of CórdobaORCID 0000-0001-8554-3802Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

José M. Villalba1 paper · University of Córdoba

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Approach:statistical model· 1

Frequent Co-Authors

Alba Calvet· 1 shared Alenka LovyiD· 1 shared Ana de Lucas‐RiusiD· 1 shared Andrea Puebla-Huerta· 1 shared Armen ZakarianiD· 1 shared Biagio MandracchiaiD· 1 shared Blanca D. López‐AyllóniD· 1 shared Camila Quezada-Gutiérrez· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alba Calvet

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell Biologynpj AgingPeer-reviewedFeb 21, 2025

Calcium (Ca2+) fluxes at Mitochondria-ER Contact Sites (MERCS) are a new target of senolysis in Therapy-Induced Senescence (TIS).

Andrea Puebla-Huerta, Hernán Huerta, Camila Quezada-Gutiérrez…·César Cárdenas

This study shows that inhibiting ER-mitochondria Ca2+ flux is a new target for senolysis in therapy-induced senescence.

22 citationstop 2%

humanexperimental assay

𝕏 PostBluesky

ImmunologyJournal of Medical VirologyPeer-reviewedJul 1, 2024

Metabolic and mitochondria alterations induced by SARS-CoV-2 accessory proteins ORF3a, ORF9b, ORF9c and ORF10

Blanca D. López‐Ayllón, Silvia Marín, Marco Fariñas Fernández…·María Montoya

This study identifies mitochondrial and metabolic reprogramming induced by SARS-CoV-2 accessory proteins in lung cells, revealing potential therapeutic targets.

28 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky